Immuneering Corp (IMRX)
About Immuneering Corp
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $0
- Net income
- -$56.0M
- Total assets
- $232.0M
- Market cap
- $276.3M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $59.4M
- Operating income
- -$59.4M
- Income tax
- $0
- Net income
- -$56.0M
- EPS (basic)
- $-1.27
- EPS (diluted)
- $-1.27
Balance sheet
- Total assets
- $232.0M
- Current assets
- $176.2M
- Total liabilities
- $13.5M
- Current liabilities
- $10.1M
- Shareholders’ equity
- $218.5M
Cash flow
- Operating cash flow
- -$45.3M
- Investing cash flow
- -$88.7M
- Financing cash flow
- $226.6M
- Net cash flow
- $92.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $276.3M
- EPS (diluted)
- $-1.27
- Shares outstanding
- 63.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 30, 2021
Immuneering Corp (IMRX) Stock Price
- Reported a net loss of $56.0M in FY2023.
- Trading 53% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Immuneering Corp.
Write a review
News about Immuneering Corp
News & sentiment via Polygon.io
Immuneering Corp: frequently asked questions
Is Immuneering Corp an American company?
Immuneering Corp is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Immuneering Corp headquartered?
Immuneering Corp is headquartered in Cambridge, Massachusetts, United States.
Is Immuneering Corp publicly traded?
Yes — Immuneering Corp is a publicly traded company. Its stock trades under the ticker symbol IMRX on the NASDAQ.
What does Immuneering Corp do?
Immuneering Corp is an American Pharmaceuticals company in the Health & Beauty sector.
